SCHEMBL257384

SCHEMBL257384

CCn1cccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257387 0.80 — —
SCHEMBL19441242 0.77 — —
SCHEMBL2058601 0.77 — —
SCHEMBL1276978 0.77 ALDH1A1 (0.47) —
SCHEMBL9664699 0.75 EEF2K (0.44) —
SCHEMBL18433170 0.73 EEF2K (0.46) —
SCHEMBL30517367 0.73 EEF2K (0.46) —
SCHEMBL28235966 0.73 EEF2K (0.46) —
SCHEMBL12301200 0.73 EEF2K (0.46) —
SCHEMBL4686019 0.73 KDM4E (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108690217-B Carbon fiber recycling composition and method 波音公司 2022-07-15 — — CN claimed
CN-109312073-A The preparation method of poly- (aryl ether sulfone) polymer and polymer composition and product comprising it 索尔维特殊聚合物美国有限责任公司 2019-02-05 — — CN claimed
CN-102050806-A Method for preparing product containing 5-hydroxymethyl furfural from lignocellulose XUE LI 2011-05-11 — — CN claimed
US-20230312524-A1 ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE CURASEN THERAPEUTICS, INC. 2023-10-05 — — US disclosed
CN-115699387-A Nonaqueous electrolyte storage element and method for manufacturing same 株式会社杰士汤浅国际 2023-02-03 — — CN disclosed
CN-108690217-B Carbon fiber recycling composition and method 波音公司 2022-07-15 — — CN disclosed
WO-2021212039-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-10-21 — — WO disclosed
WO-2021126693-A1 GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2021-06-24 — — WO disclosed
US-20200247812-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE INTEGRAL BIOSCIENCES PRIVATE LTD (IN) 2020-08-06 — — US disclosed
WO-2020015964-A1 PHOTO-CURABLE RESIN COMPOSITION FOR 3D PRINTING CLARIANT INTERNATIONAL LTD (CH) 2020-01-23 — — WO disclosed
CN-109563082-A Magnetic resonance imaging compound, wherein mesosome, magnetic resonance imaging agent and application and magnetic resonance imaging method employing 北京市神经外科研究所 2019-04-02 — — CN disclosed
US-20090048223-A1 Sulfonamide compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-02-19 — — US disclosed
EP-1567518-B1 OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS CIBA HOLDING INC (CH) 2009-01-14 — — EP disclosed
EP-1932841-A1 SULFONAMIDE COMPOUND Asahi Kasei Pharma Corporation (JP) 2008-06-18 — — EP disclosed
CN-101156275-A Electrolyte composition for photoelectric converter and photoelectric converter using the same NIPPON KAYAKU KK (JP) 2008-04-02 — — CN disclosed
CN-101142643-A Electrochemical cell SII MICRO PARTS LTD (JP) 2008-03-12 — — CN disclosed
US-20070179127-A1 Sulfonamide compound ASAHI KASEI PHARMA CORPORATION (JP) 2007-08-02 — — US disclosed
WO-2004052847-A2 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-06-24 — — WO disclosed
EP-0248393-B1 METHOD FOR THE PREPARATION OF ACYLATED HETEROAROMATICS AT ZEOLITHIC CATALYSTS BASF Aktiengesellschaft (DE) 1991-08-07 — — EP disclosed
EP-0248393-A1 Method for the preparation of acylated heteroaromatics at zeolithic catalysts BASF Aktiengesellschaft (DE) 1987-12-09 — — EP disclosed
Send feedback